 Results from the APOLLO-B study are due any day now and will significantly impact sentiment around ALNY shares, as well as the revenue potential of Onpattro. A clearly successful outcome could quadruple revenue, but its possible that the trial could meet its primary outcome and fail to show sufficient benefits in secondary outcomes or vice versa. 